<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=1000083763474443&amp;ev=PageView&amp;noscript=1">

SmartTRAK Life Sciences News and Analysis Blog

3 min read

Leveraging Government Affairs for Commercial Success: An Interview w/ Jack Kalavritinos

By Gary Delhougne on 5/26/22 9:30 AM

Jack Kalavritinos, Former HHS/FDA Senior Official and Principal of JK Strategies, discusses the importance and benefits of government affairs in medtech

Jack Kalavritinos is the Founder and Principal of JK Strategies, a communications and public policy firm that helps organizations develop winning communication and policy strategies. Jack is also a former senior government official and appointee in HHS, FDA and DOL. Jack has decades of Washington, DC government, political and business experience including in the medtech sector with Covidien.

In this interview with SmartTRAK, Jack shares his thoughts on the benefits to medtech commercial leaders of developing collaborative relationships with their government affairs colleagues. Specifically, SmartTRAK’s interview with Jack covers the next phases of the COVID-19 public health emergency, the potential impact of the midterm elections and ways companies can work with the FDA.

To find out more, including Jack’s take on how medtech commercial leaders can develop relationships with their Representatives and Senators, click on the following video recorded live via Zoom. Outlined below are specific interview topics by the minute. To download a complete transcript of the interview, click here.

Continue Reading
2 min read

Meet with SmartTRAK at ISASS 2022

By Thomas Wallick on 5/25/22 10:03 AM

The SmartTRAK team will be attending the upcoming International Society for the Advancement of Spine Surgery (ISASS) in The Bahamas and we would love to schedule some time to meet. We are particularly excited about this year’s conference program and speakers.

Our team of expert analysts have their finger on the pulse on the spine industry trends, news, financial data and competitor developments. We would like to meet to hear your perspectives and views and discuss how SmartTRAK can help you make more informed strategic business decisions.

Watch the video below to meet Courtney Sheedy, SmartTRAK's GM, Spine


Meet Us at ISASS

Build an Enterprise of Experts, so your
Company can build the next big thing.

Continue Reading
10 min read

What’s New in Neuromodulation for Spring 2022

By Anne Staylor on 5/23/22 11:52 AM

In the market for neuromodulation, companies are developing spinal cord stimulation (SCS), deep brain stimulation (DBS) and other stimulation devices designed to treat a vast range of indications. Current and emerging devices are addressing care gaps in the treatment of chronic pain and movement disorders as well as epilepsy, Tourette syndrome, depression, pelvic floor dysfunction, peripheral artery disease, paralysis and spinal cord injuries.

Companies competing in the market for neuromodulation include Abbott*, Boston Scientific*, Medtronic*, Nevro*, Saluda Medical*, Newronika* and Axonics, just to name a few. To keep you up to speed on what’s new in neuromodulation, SmartTRAK highlights market updates covering clinical developments, patents, new research and other top news from Spring 2022.

SmartTRAK's Anne Staylor, Executive Editor, VP &GM of Neurotherapies, is in Barcelona attending the INS 15th Congress.

The following is just a small sampling of recent neuromodulation updates from around the world compiled, reviewed and posted daily by our SmartTRAK analysts.

Clinical Developments

  • Medtronic*
    • Medtronic announced the first patient implanted in its “Evaluation of Long-term Patient Experience with a Medtronic Closed-Loop SCS System” study of its investigative, closed-loop, ECAP-responsive device to treat back and limb pain. The prospective study is enrolling 90 patients across 10 centers in Australia.
    • A University of Florida-sponsored eight patient clinical trial will evaluate DBS to treat Tourette syndrome targeting two brain regions in each hemisphere of each patient and using two leads in each hemisphere connected to two Percept PC devices. Estimated study completion is Aug 2026. clinicaltrials.gov

  •  Boston Scientific*
    • Boston Scientific received FDA approval of its latest image-guided programming software, Vercise Neural Navigator with STIMVIEW XT. Developed in collaboration with Brainlab*, STIMVIEW XT provides real-time visualization of lead position and simulation modeling for Parkinson’s Disease and essential tremor treatment.
Continue Reading
5 min read

Trends in Product and IT-Driven Innovations: SAWC Spring 2022

By Gary Delhougne on 5/19/22 10:56 AM

Emerging from the COVID-19 era, wound care innovation is driven by smaller companies

In April, the Symposium on Advanced Wound Care (SAWC) Spring 2022 returned to an in-person format for the first time since 2019. Though the turnout was below expectations, attendees enjoyed reconnecting with clinicians, engaging with vendors and catching up with colleagues and competitors.

Despite being three years since the last SAWC Spring, large wound care companies like Smith+Nephew* (SNN), Mölnlycke*, 3M* and others were oddly without major product introductions. SmartTRAK has learned that extended FDA review timelines and supply challenges may be playing a significant role in this reality. Companies have publicly commented that innovation and new product launches are planned for 2022, but timelines must have slipped past the SAWC Spring deadlines.

Regardless, innovation was not completely absent from SAWC Spring as smaller companies introduced new products and more companies exhibited IT-driven diagnostic, measurement and data-capture technologies.

(The SmartTRAK team will be attending the upcoming European Wound Management Association (EWMA) event May 23-25 in Paris. We would love to schedule some time to meet and hear your perspectives and views and discuss how SmartTRAK can help you make more informed strategic business decisions.)

In this article, SmartTRAK highlights new products and novel technologies exhibited at SAWC Spring 2022.

Topics: Wound Care
Continue Reading
5 min read

Wound Care Today 2022 – Looking Ahead with Cautious Optimism

By Kris Flinn on 5/17/22 9:00 AM

Increased wound prevalence meets new software and solutions at WCT 2022.

There was a positive energy in the room at the 5th Wound Care Today (WCT) conference as industry and clinicians came together in Milton Keynes. COVID-19 infection rates remain high in the UK but this is not being reflected in hospitalizations or deaths, leading to a national determination to move forward without restrictions. The pandemic has, however, shaped the priorities of those present and in a range of discussions. SmartTRAK encountered a commercial eagerness to make up for lost time and a looming burden of chronic wounds.

The SmartTRAK team will be attending the upcoming European Wound Management Association (EWMA) event May 23-25 in Paris. We would love to schedule some time to meet and hear your perspectives and views and discuss how SmartTRAK can help you make more informed strategic business decisions.

Continue Reading
5 min read

Total Joints: Trends to Watch in 2022

By Lisa Mahan on 5/16/22 10:27 AM

From economics to the ASC shift, SmartTRAK looks at the trends affecting the Total Joints Market

The start of the new year did not play out as so many of us had hoped. Heading into 2022, the next COVID surge reared its ugly head with the Omicron variant storming through countries around the globe. Healthcare facilities once again postponed elective procedures due to capacity issues and/or staff or patients being diagnosed with COVID. Overall inflation rose to a level that hasn’t been seen since the early 1980s. Looking ahead, is there a silver lining in this dark cloud? SmartTRAK believes the forecast is not all doom and gloom. Let’s look at some of the trends affecting the climate of the Total Joints market.

(Continue reading to find out how to receive FREE SmartTRAK DAILY UPDATES)

Continue Reading
2 min read

Trends To Watch in 2022: Injectable Regenerative Medicine Therapies

By Freddy Buntoum on 5/10/22 9:00 AM

From the impact of stringent regulations to the shift toward new indications and rising market segments, SmartTRAK explores some of the trends to watch for in 2022 and beyond.

Orthopedic regenerative medicine therapy as an emerging area of science holds great promise for treating and promoting faster healing in a variety of injuries. There is also a belief among some scientists and industry stakeholders that it may hold the key to halting or reversing degenerative chronic conditions through self-healing. In a previous article, SmartTRAK had highlighted several challenges that Regenerative Medicine therapies would need to overcome to become a fully viable business and recognized treatment solution for patients. In 2021, businesses, societies and health care systems across the world continued to experience disruptions from the COVID-19 pandemic and its subsequent waves of variants. Furthermore, much greater scrutiny and tougher regulations for some of the injectable regenerative medicine therapies were put into place. The start of 2022 is also not quite as “rosy” as most had hoped for ...

Download the complete Injectable Regen Medicine article

Continue Reading
3 min read

Bone Computers that Monitor and Improve Musculoskeletal Health: Osseosurface Electronics

By Nick Fitzpatrick on 5/5/22 12:14 PM

In an interview with SmartTRAK, University of Arizona professor Dr. Philipp Gutruf discusses research on a new class of bioelectronics he calls osseosurface electronics and its application in the orthopedic field. Dr. Gutruf is an Assistant Professor in the Biomedical Engineering Department at the University of Arizona and his research group focuses on creating devices that integrate with biological systems by combining innovations in soft materials, photonics and electronics to create systems with broad impact on health diagnostics, therapeutics and exploratory neuroscience. 

Topics: Orthopedics
Continue Reading
4 min read

The State of Cybersecurity in Healthcare

By Nick Fitzpatrick on 5/3/22 9:00 AM

Jason Winkler, Sales VP of cybersecurity startup Device Authority, discusses the state of cybersecurity in healthcare in an interview with SmartTRAK.

In an interview with SmartTRAK, Device Authority VP of Sales (Americas) Jason Winkler discusses the state of cybersecurity in healthcare and medical devices.

To find out more, including the devices most vulnerable to cybersecurity threats and how medical device manufacturers should think about designing cybersecurity measures into their connected products, click on the following video to listen to the full interview (17:29 min). A link to download the complete transcript of the interview is also provided below.

Continue Reading
3 min read

Real-Time Spinal Navigation: An Interview w/ Pathkeeper Surgical's CEO Erez Lampert

By Nick Fitzpatrick on 4/28/22 9:30 AM

Erez Lampert, CEO and Founder of Israeli start-up Pathkeeper Surgical, discusses the Company’s real-time spinal navigation system that’s generating high interest from ASCs in an interview with SmartTRAK 


In an interview with SmartTRAK, Pathkeeper Surgical CEO and Founder Erez Lampert discusses Pathkeeper’s mobile, light-weight spinal navigation system. 

To find out more, including the timeline for FDA approval and demand from surgeons, hospitals and ASCs, click on the following video to listen to the full interview (22:29 min). A link to download the complete transcript of the interview is also provided below.

Continue Reading

    Follow Us on Social Media

    Recent Articles